Viewing Study NCT00116012


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT00116012
Status: COMPLETED
Last Update Posted: 2006-11-29
First Post: 2005-06-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32
Sponsor: ARCA Biopharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module